Patient Portal Technologies (OTCMKTS:PPRG) & Tempus AI (NASDAQ:TEM) Financial Contrast
by Doug Wharley · The Cerbat GemPatient Portal Technologies (OTCMKTS:PPRG – Get Free Report) and Tempus AI (NASDAQ:TEM – Get Free Report) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, earnings, valuation, dividends, profitability, risk and analyst recommendations.
Institutional & Insider Ownership
24.2% of Tempus AI shares are owned by institutional investors. 26.3% of Tempus AI shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.
Earnings & Valuation
This table compares Patient Portal Technologies and Tempus AI”s revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Patient Portal Technologies | N/A | N/A | N/A | N/A | N/A |
| Tempus AI | $693.40 million | 17.62 | -$705.81 million | ($1.19) | -57.71 |
Patient Portal Technologies has higher earnings, but lower revenue than Tempus AI.
Profitability
This table compares Patient Portal Technologies and Tempus AI’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Patient Portal Technologies | N/A | N/A | N/A |
| Tempus AI | -18.45% | -73.21% | -13.78% |
Analyst Ratings
This is a breakdown of current ratings and price targets for Patient Portal Technologies and Tempus AI, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Patient Portal Technologies | 0 | 0 | 0 | 0 | 0.00 |
| Tempus AI | 1 | 7 | 7 | 0 | 2.40 |
Tempus AI has a consensus target price of $85.36, suggesting a potential upside of 24.31%. Given Tempus AI’s stronger consensus rating and higher possible upside, analysts clearly believe Tempus AI is more favorable than Patient Portal Technologies.
Summary
Tempus AI beats Patient Portal Technologies on 6 of the 9 factors compared between the two stocks.
About Patient Portal Technologies
Patient Portal Technologies, Inc. provides patient relationship management solutions for healthcare facilities, patients and families, and medical personnel. It offers HEALTHCAST, a multi-channel, television network for the delivery of customized information and education to patients, visitors, and staff; MEDEX PRESCRIPTION DELIVERY, a free prescription medication delivery solution; and PHONE & TV RENTAL, an interactive communication center, and billing and collection platform. The company also provides TELCIERGE INSTANT RESPONSE that puts patients in control of non-medical needs through a single phone call; QUICK PULSE SURVEYS that provide feedback for improved operations; and MEDCLIPS, which provide condition specific video clips for internal or remote viewing before or after hospital stay. Patient Portal Technologies, Inc. is based in Baldwinsville, New York.
About Tempus AI
Tempus AI Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. Tempus AI Inc. is based in CHICAGO.